In this interview, Dr. Priya Koilpillai and Dr. Sudhir Nishtala discuss the latest evidence, risks and benefits of low-dosage acetylsalicylic acid in primary and secondary prevention of cardiovascular disease.Dr. Koilpillai is a second year internal medicine resident at the University of Calgary who has a keen interest in medical education and women’s cardiovascular health. Dr. Nishtala is a former cardiac intensive care pharmacist and now is a cardiology fellow at the University of Calgary Libin Cardiovascular Institute.The Practice article they co-authored is titled “Five things to know about...the cardiovascular benefits of low-dosage acetylsalicylic acid.” The article is published in CMAJ: www.cmaj.ca/lookup/doi/10.1503/cmaj.191037Podcast transcript: https://www.cmaj.ca/transcript-191037-----------------------------------This podcast episode is brought to you by Dr. Bill.Dr. Bill is an easy-to-use mobile and web solution that truly simplifies the way you do medical billing. Join over 1500 physicians already using our billing software to save time, boost productivity and earn more. Visit www.dr-bill.ca for more information.-----------------------------------Subscribe to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.

Comments or questions? Text us.

Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.

You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole

X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca

The CMAJ Podcast is produced by PodCraft Productions

Cardiovascular benefits of acetylsalicylic acid (ASA) in primary and secondary prevention